Table 2. Reviewed Histologic Diagnosis... | American Society of Hematology

Table 2.

Reviewed Histologic Diagnosis in 51 Anti-HCV⁺ Patients With CLD: Grading, Staging, HAI, and Serologic Markers

	HBV-HCV 14 pts^*	HCV 37 pts^†
Grading
Mild	8 (57%)	28 (76%)
Moderate	5 (36%)	7 (19%)
Severe	1 (7%)	2 (5%)
Staging
1	3 (21.5%)	24 (65%)
2	7 (50%)	8 (21.5%)
3	1 (7%)	4 (11%)
4	3 (21.5%)	1 (2.5%)
HAI^‡
2	5	6
3	0	11
4	4	12
5	3	3
6	1	2
7	1	3

	HBV-HCV 14 pts^*	HCV 37 pts^†
Grading
Mild	8 (57%)	28 (76%)
Moderate	5 (36%)	7 (19%)
Severe	1 (7%)	2 (5%)
Staging
1	3 (21.5%)	24 (65%)
2	7 (50%)	8 (21.5%)
3	1 (7%)	4 (11%)
4	3 (21.5%)	1 (2.5%)
HAI^‡
2	5	6
3	0	11
4	4	12
5	3	3
6	1	2
7	1	3

Abbreviation: pts, patients.

Two patients were anti-HCV-HBV-HDV⁺.

Five patients were anti-HBsAg/HBc⁺.

No liver biopsy sample showed HAI 1 or greater than 7.